亞太地區直接面對消費者的基因檢測市場預測至 2030 年 - 區域分析 - 按檢測類型、技術和配銷通路
市場調查報告書
商品編碼
1463716

亞太地區直接面對消費者的基因檢測市場預測至 2030 年 - 區域分析 - 按檢測類型、技術和配銷通路

Asia Pacific Direct-to-Consumer Genetic Testing Market Forecast to 2030 - Regional Analysis - by Test Type, Technology, and Distribution Channel

出版日期: | 出版商: The Insight Partners | 英文 78 Pages | 訂單完成後即時交付

價格

2022年亞太地區直接面對消費者的基因檢測市場價值為3.5424億美元,預計到2030年將達到15.3084億美元;預計2022年至2030年CAGR為20.1%。

單核苷酸多態性 (SNP) 晶片的日益普及推動了亞太地區直接面對消費者的基因檢測市場

近年來,隨著科學知識的增加,從傳統醫學向個人化醫學的典範穩步轉變。這種轉變歸功於基因工程、單核苷酸多態性 (SNP) 基因分型以及微陣列和生物晶片技術的廣泛採用。具有數十萬個 SNP 的基因微陣列分析平台的引入將鼓勵先進演算法的實施,以更公開地測試個體之間更隱蔽的家譜關係。此外,檢測惡性腫瘤的需求也有所增加。在兒科領域,由於無需將 SNP 變異與大規模缺失雜交,週轉時間短,因此產生了巨大的需求。因此,隨著更多基因異常的檢測和治療,市場預計將會成長。

由於對技術先進和更複雜的 DTC 基因檢測的持續需求,高效、準確的 SNP 晶片的需求不斷增加。人們對 SNP 晶片的高度偏好可歸因於它們能夠測量劑量變化和 DNA 多態性,以及對癌症研究至關重要的各種應用,例如 SNP 微陣列分析。此外,對盡量減少 DTC 基因檢測錯誤的需求日益成長,預計將推動 SNP 技術的採用,為市場成長提供機會。

亞太地區直接面對消費者的基因檢測市場概況

亞太地區直接面對消費者的基因檢測市場細分為中國、日本、印度、澳洲、韓國和亞太其他地區。預計在預測期內,該地區的市場將以全球所有主要地區中最快的速度成長。亞太地區直接面對消費者的基因檢測市場的激增歸因於對優質治療解決方案的需求不斷增加、對遺傳性疾病早期篩檢意識的提高以及對研發活動的日益關注。此外,基因組學研發的激增、大量患者以及醫療基礎設施的升級預計將有利於預測期內亞太地區直接面對消費者的基因檢測市場的成長。

亞太地區直接面對消費者的基因檢測市場收入及 2030 年預測(百萬美元)

亞太地區直接面對消費者的基因檢測市場區隔

亞太地區直接面對消費者的基因測試市場分為測試類型、技術、配銷通路和國家。

根據測試類型,亞太地區直接面對消費者的基因測試市場分為血統測試、預測測試、營養基因組學測試、帶因者測試等。 2022 年,血統測驗細分市場佔據最大佔有率。

從技術面來看,亞太直接面對消費者的基因檢測市場分為全基因組定序、單核苷酸多態性晶片、標靶分析等。 2022年,單核苷酸多態性晶片領域佔據最大佔有率。

根據配銷通路,亞太地區直接面對消費者的基因檢測市場分為線上和線下。 2022 年,線上細分市場佔據了更大的佔有率。

依國家/地區分類,亞太地區直接面對消費者的基因檢測市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2022年,中國在亞太地區直接面對消費者的基因檢測市場佔據主導地位。

Genesis Healthcare Co、Ancestry Genomics Inc、Myriad Genetics, Inc.、Living DNA Ltd、23andMe Inc 和 Genetic Technologies Ltd 是亞太地區直接面對消費者的基因檢測市場的一些領先公司。

目錄

表中的內容

第 1 章:簡介

第 2 章:執行摘要

  • 重要見解

第 3 章:研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章:亞太地區直接面對消費者的基因檢測市場格局

  • 概述

第 5 章:亞太地區直接面對消費者的基因檢測市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病的發生率不斷上升
    • 提高對基因檢測潛在益處的認知
  • 市場限制
    • 與直接面對消費者的基因檢測相關的高成本和隱私問題
  • 市場機會
    • 單核苷酸多態性 (SNP) 晶片的採用日益廣泛
  • 未來的趨勢
    • 人們對藥物基因學的興趣日益濃厚,遠距醫療的採用也不斷增加
  • 影響分析

第 6 章:直接面對消費者的基因檢測市場 - 亞太市場分析

  • 概述
  • 亞太地區直接面對消費者的基因檢測市場收入,2022 - 2030

第 7 章:亞太地區直接面對消費者的基因測試市場 - 收入和 2030 年預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年亞太地區直接面對消費者的基因測試市場收入佔有率(按測試類型分類)
  • 血統測試
  • 營養基因組學測試
  • 預測測試
  • 營運商測試
  • 其他

第 8 章:亞太地區直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年和 2030 年亞太地區直接面對消費者的基因檢測市場收入佔有率(按技術分類)
  • 全基因組定序
  • 單核苷酸多態性晶片
  • 針對性分析
  • 其他

第 9 章:亞太地區直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 按配銷通路

  • 概述
  • 2022 年和 2030 年亞太地區直接面對消費者的基因檢測市場收入佔有率(按配銷通路分類)(%)
  • 線上平台
  • 線下平台

第 10 章:亞太地區直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 國家分析

  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 餘下的

第 11 章:亞太地區直接面對消費者的基因檢測市場-產業格局

  • 概述
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 12 章:公司簡介

  • Genesis Healthcare Co
  • Ancestry Genomics Inc
  • Myriad Genetics, Inc.
  • Living DNA Ltd
  • 23andMe Inc
  • Genetic Technologies Ltd

第 13 章:附錄

Product Code: BMIRE00029624

The Asia Pacific direct-to-consumer genetic testing market was valued at US$ 354.24 million in 2022 and is expected to reach US$ 1,530.84 million by 2030; it is estimated to grow at a CAGR of 20.1% from 2022 to 2030.

Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips Fuels the Asia Pacific Direct-to-Consumer Genetic Testing Market

There has been a steady paradigm shift from traditional medicine to personalized medicine with increasing scientific knowledge in recent years. This shift is due to advances in genetic engineering, single nucleotide polymorphism (SNP) genotyping, and the high adoption of microarrays and biochip technologies. The introduction of genetic microarray analysis platforms with hundreds of thousands of SNPs will encourage the implementation of advanced algorithms to test for more secluded genealogical relationships more openly between individuals. In addition, the demand for detecting malignant tumors has also increased. In the pediatric field, the short turnaround time without the need to hybridize SNP variations to massive deletions has led to enormous demand. As a result, the market is expected to grow as more genetic abnormalities are detected and treated.

SNP chips with high efficiency and accuracy are witnessing an increase in demand due to the constant need for technologically advanced and more sophisticated DTC genetic testing. A high preference for SNP chips can be attributed to their ability to measure dosage changes and DNA polymorphism, along with various applications such as the SNP microarray analysis that are vital for cancer research. Furthermore, an increasing need to minimize errors in DTC genetic testing is expected to drive the adoption of SNP technology, thereby providing an opportunity for the market growth.

Asia Pacific Direct-to-Consumer Genetic Testing Market Overview

The Asia Pacific direct-to-consumer genetic testing market is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in this region is expected to grow at the fastest pace among all major regions in the world during the forecast period. The proliferation of the direct-to-consumer genetic testing market in Asia Pacific is attributed to the increasing need for superior treatment solutions, a rise in awareness of the early screening of genetic disorders, and the growing focus on research and development activities. Additionally, an upsurge in the R&D for genomics, a large pool of patients, and upgrades in healthcare infrastructure are projected to favor the growth of the direct-to-consumer genetic testing market in Asia Pacific during the forecast period.

Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation

The Asia Pacific direct-to-consumer genetic testing market is segmented into test type, technology, distribution channel, and country.

Based on test type, the Asia Pacific direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.

In terms of technology, the Asia Pacific direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.

Based on distribution channel, the Asia Pacific direct-to-consumer genetic testing market is bifurcated into online and offline. The online segment held a larger share in 2022.

Based on country, the Asia Pacific direct-to-consumer genetic testing market is segmented China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific direct-to-consumer genetic testing market in 2022.

Genesis Healthcare Co, Ancestry Genomics Inc, Myriad Genetics, Inc., Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd are some of the leading companies operating in the Asia Pacific direct-to-consumer genetic testing market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Direct-to-Consumer Genetic Testing Market Landscape

  • 4.1 Overview

5. Asia Pacific Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Incidence of Genetic Disorders
    • 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
  • 5.4 Future Trends
    • 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
  • 5.5 Impact Analysis

6. Direct-to-Consumer Genetic Testing Market - Asia Pacific Market Analysis

  • 6.1 Overview
  • 6.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Ancestry Testing
    • 7.3.1 Overview
    • 7.3.2 Ancestry Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Nutrigenomics Testing
    • 7.4.1 Overview
    • 7.4.2 Nutrigenomics Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Predictive Testing
    • 7.5.1 Overview
    • 7.5.2 Predictive Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Carrier Testing
    • 7.6.1 Overview
    • 7.6.2 Carrier Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Whole Genome Sequencing
    • 8.3.1 Overview
    • 8.3.2 Whole Genome Sequencing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Single Nucleotide Polymorphism Chips
    • 8.4.1 Overview
    • 8.4.2 Single Nucleotide Polymorphism Chips: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Targeted Analysis
    • 8.5.1 Overview
    • 8.5.2 Targeted Analysis: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Online Platform
    • 9.3.1 Overview
    • 9.3.2 Online Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Offline Platform
    • 9.4.1 Overview
    • 9.4.2 Offline Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Asia Pacific Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
    • 10.1.1 Asia Pacific Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
      • 10.1.1.1 China: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.2 China: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.3 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.3 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.4 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.5 India: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.6 India: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.3 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.7 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.8 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.8.1 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.8.2 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.8.3 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.9 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.10 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.10.1 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.10.2 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.10.3 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.11 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.12 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.12.1 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.12.2 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.12.3 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)

11. Asia Pacific Direct-to-Consumer Genetic Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Genesis Healthcare Co
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Ancestry Genomics Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Myriad Genetics, Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Living DNA Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 23andMe Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Genetic Technologies Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation
  • Table 2. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel- Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Organic Developments Done by Companies
  • Table 21. Inorganic Developments Done by Companies
  • Table 22. Glossary of Terms, Asia Pacific Direct-to-Consumer Genetic Testing Market

List Of Figures

  • Figure 1. Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation, By Country
  • Figure 2. Asia Pacific Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
  • Figure 3. Asia Pacific Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 6. Ancestry Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Nutrigenomics Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Predictive Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 12. Whole Genome Sequencing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Single Nucleotide Polymorphism Chips: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Targeted Analysis: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 17. Online Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Offline Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 20. Asia Pacific Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
  • Figure 21. China: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. India: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)